The Critical Importance of an Ethical, a Responsible, and a Sustainable AI Strategy for Pharma

This IDC Perspective discusses evolving regulations and industry initiatives around ethical, responsible, and sustainable AI in pharma; highlights evolving roles and implementation strategies; and provides guidance to the tech buyer as well. "AI and GenAI, in particular, are rapidly disrupting the life science industry today. While the industry is moving fast to leverage the promise of AI, it is essential to establish ethical, responsible, and sustainable AI frameworks, embedding transparency, fairness, and patient centricity in the AI fabric. New roles, such as digital ethicists and privacy strategy managers, will play a key role in evolving these AI strategies and building trust and credibility for the pharma industry. At all times, it will be essential for an ethical compass to drive AI strategy in the life science industry. Inclusiveness and representativeness will be foundational to the success of applying these AI strategies to the life science industry," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.